City
Epaper

Dr Dangs Lab as central lab conducted tests in all three trial phases of Corbevax COVID-19 vaccine, says Dr Arjun Dang

By ANI | Published: December 29, 2021 6:05 PM

With the Drug Controller General of India (DCGI) approving two new COVID-19 vaccines and one anti-viral drug for emergency use on Tuesday, Dr Arjun Dang, CEO, Dr Dangs Lab, welcomed the announcement and said they feel immensely proud "to have been a part of this momentous journey as the central lab of choice for an end-to-end services" concerning Corbevax vaccine

Open in App

With the Drug Controller General of India (DCGI) approving two new COVID-19 vaccines and one anti-viral drug for emergency use on Tuesday, Dr Arjun Dang, CEO, Dr Dangs Lab, welcomed the announcement and said they feel immensely proud "to have been a part of this momentous journey as the central lab of choice for an end-to-end services" concerning Corbevax vaccine.

"Dr Dangs Lab conducted screening, safety and several immunogenicity tests for all the three phases of the Corbevax which were multi-centric, ensuring seamless project management, timely submission of results, accurate lab assays, and efficient bio-repository management. This called for close coordination with participating investigative sites, principal investigators as well as efficient handling of pan-India logistics," Dr Arjun Dang said.

Biological E limited's COVID-19 vaccine Corbevax is the first indigenously developed protein-subunit vaccine against COVID19 which utilizes the receptor-binding domain from the spike protein as the vaccine antigen.

Protein subunit class of vaccines have been used successfully against multiple viral pathogens for many years and are known for excellent safety profile and consistent immune response which was also demonstrated in the comprehensive Phase 1, 2 and 3 clinical trials conducted at more than 30 sites in India.

Dr Dangs Lab in New Delhi conducted and participated in the screening and immunogenicity tests for all three phases following stringent quality norms driven by GCLP guidelines as mandated by regulatory authorities.

Dr Arjun Dang said the lab has renowned experts in each field "who worked tirelessly and collectively to provide quality and timely results to fulfil the imminent need for an effective and safe COVID-19 vaccine".

"Dr Dangs Lab is a premium lab chain in Delhi and NCR renowned for its personalised and quality-based diagnostic services and has also partnered with various institutes and companies for academic research and clinical trials in the past," he said.

Corbevax is the third made-in-India vaccine against coronavirus, the other two indigenous vaccines are Covaxin and ZyCoV-D.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: New DelhidelhiDr dangs labNCRArjun dang
Open in App

Related Stories

InternationalCBI Arrests 4 for Trafficking Indians Into Russia-Ukraine Conflict Zone (See Tweet)

NationalDelhi Weather Update: IMD Predicts Cloudy Sky, Dust Storm

BusinessGold Rate on May 7, 2024: Check Prices of Yellow Metal in Mumbai, Delhi and Other Cities

NationalDelhi Firing Incident: Multiple Shots Fired At Car Showroom In Tilak Nagar (Watch Video)

NationalFake Masala Scam Busted in Delhi: Police Seize 15 Tonnes of Spurious Spices from Factories in Karawal Nagar, Three Arrested

National Realted Stories

NationalTN Congress moves Madras HC against PM’s election speeches

National‘Caught Up With My Young Friend’: PM Narendra Modi Shares Heartwarming Moment With Child in Telangana, See Pic

NationalBSP Hoshiarpur Lok Sabha candidate Rakesh Soman joins AAP

NationalExcise Policy Case: Delhi HC Dismisses PIL Seeking Facilities for Arvind Kejriwal in Jail

NationalMoCA Presses Air India Express for Answers After Crew Members' 'Mass Sick Leave', Passengers Stranded